ELV240920C660000
- 1.09
- 0.000.00%
Elevance Health Newsroom
Elevance Health Price Target Maintained With a $600.00/Share by Cantor Fitzgerald
Elevance Health Analyst Ratings
Stephens Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $615
Wells Fargo Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $593
Wells Fargo Reaffirms Their Buy Rating on Elevance Health (ELV)
Cantor Fitzgerald Reiterates Overweight on Elevance Health, Maintains $600 Price Target
Elevance Health Analyst Ratings
Jefferies Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $600
Elevance Health (ELV) Gets a Buy From Jefferies
JPMorgan Adjusts Price Target on Elevance Health to $655 From $631
Centene Downgraded at Jefferies Amid Higher Medicaid Utilization
Elevance Health Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Elevance Health, Maintains $600 Price Target
Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $593
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)
TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589
Elevance Health Analyst Ratings
Baird Adjusts Price Target on Elevance Health to $625 From $649
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Elevance Health (ELV) Receives a Buy From Truist Financial